19-52950256-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001202457.3(ZNF816):āc.1519A>Cā(p.Lys507Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,613,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 33)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
ZNF816
NM_001202457.3 missense
NM_001202457.3 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
ZNF816 (HGNC:26995): (zinc finger protein 816) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be integral component of membrane. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22964007).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF816 | NM_001202457.3 | c.1519A>C | p.Lys507Gln | missense_variant | 4/4 | ENST00000444460.7 | NP_001189386.1 | |
ZNF816-ZNF321P | NM_001202473.2 | c.190+2495A>C | intron_variant | NP_001189402.1 | ||||
ZNF816 | NM_001031665.4 | c.1519A>C | p.Lys507Gln | missense_variant | 5/5 | NP_001026835.1 | ||
ZNF816 | NM_001202456.3 | c.1519A>C | p.Lys507Gln | missense_variant | 4/4 | NP_001189385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF816 | ENST00000444460.7 | c.1519A>C | p.Lys507Gln | missense_variant | 4/4 | 1 | NM_001202457.3 | ENSP00000403266 | P1 | |
ZNF816 | ENST00000357666.8 | c.1519A>C | p.Lys507Gln | missense_variant | 5/5 | 1 | ENSP00000350295 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151968Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
151968
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251392Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135878
GnomAD3 exomes
AF:
AC:
2
AN:
251392
Hom.:
AF XY:
AC XY:
1
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461646Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727102
GnomAD4 exome
AF:
AC:
3
AN:
1461646
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
727102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151968Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74216
GnomAD4 genome
AF:
AC:
2
AN:
151968
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2022 | The c.1519A>C (p.K507Q) alteration is located in exon 5 (coding exon 3) of the ZNF816 gene. This alteration results from a A to C substitution at nucleotide position 1519, causing the lysine (K) at amino acid position 507 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Uncertain
T;T
Polyphen
D;D
Vest4
MutPred
Loss of methylation at K507 (P = 0.0015);Loss of methylation at K507 (P = 0.0015);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at